MediFind found 83 doctor with experience in Relapsed Refractory Multiple Myeloma (RRMM) near San Francisco, CA. Of these, 61 are Experienced, 14 are Advanced, 6 are Distinguished and 2 are Elite.
Ucsf Medical Group Business Services
Ajai Chari is a Hematologist Oncology specialist and a Hematologist in Berkeley, California. Dr. Chari is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Ucsf Medical Group Business Services
Thomas Martin is a Hematologist and an Oncologist in Berkeley, California. Dr. Martin is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of California San Francisco
Michael Rabow is a Palliative Medicine provider in San Francisco, California. Dr. Rabow is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Chronic Pain, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, and ALK-Positive Non-Small Cell Lung Cancer.
University Of California San Francisco
Nancy Wong is a Nurse Practitioner in San Francisco, California. Ms. Wong is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
University Of California San Francisco
Jeffrey Wolf is a Hematologist and an Oncologist in San Francisco, California. Dr. Wolf is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of California San Francisco
Nina Shah is a Hematologist and an Oncologist in San Francisco, California. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Ucsf Medical Group Business Services
Sandy Wong is a Hematologist and an Oncologist in San Francisco, California. Dr. Wong has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Aspiration, and Bone Marrow Transplant.
Regents Of The University Of California
Shagun Arora is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Arora is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration.
Ucsf Medical Group Business Services
Alfred Chung is a Hematologist in San Francisco, California. Dr. Chung is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
UCSF Department Of Laboratory Medicine
William Karlon is a Hematologist in San Francisco, California. Dr. Karlon is rated as an Experienced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Non-Hodgkin Lymphoma, Multiple Myeloma, and Gastric Lymphoma.
Amy Marsala is a Nurse Practitioner in San Francisco, California. Ms. Marsala is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Smoldering Multiple Myeloma and Relapsed Refractory Multiple Myeloma (RRMM).
University Of California San Francisco
Lawrence Kaplan is an Oncologist and a Hematologist in San Francisco, California. Dr. Kaplan is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Lissa Sturdevant is a Nurse Practitioner in San Francisco, California. Ms. Sturdevant is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
University Of California San Francisco
Samantha Shenoy is a Nurse Practitioner in San Francisco, California. Ms. Shenoy is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Febrile Neutropenia, and Bone Marrow Aspiration.
Regents Of The University Of California
Rebecca Olin is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Olin is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Regents Of The University Of California
Aaron Logan is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Logan is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Graft Versus Host Disease (cGvHD), Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of California San Francisco
Peter Sayre is a Hematologist and an Oncologist in San Francisco, California. Dr. Sayre is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Regents Of The University Of California
Lloyd Damon is an Oncologist and a Hematologist in San Francisco, California. Dr. Damon is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Regents Of The University Of California
Charalambos Andreadis is an Oncologist and a Hematologist in San Francisco, California. Dr. Andreadis is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of California San Francisco
Bradley Ekstrand is a Hematologist Oncology specialist and an Oncologist in San Francisco, California. Dr. Ekstrand is rated as an Advanced provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Follicular Lymphoma, Familial Prostate Cancer, Small Lymphocytic Lymphoma (SLL), and Large-Cell Immunoblastic Lymphoma.
Last Updated: 01/09/2026